Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomide in patients with rheumatoid arthritis?

特瑞氟米特 来氟米特 类风湿性关节炎 医学 内科学 药品 药理学 活性代谢物 代谢物 免疫学 多发性硬化 芬戈莫德
作者
R. Tekaya,Ben Tekaya Aicha,Ben Ammar Lobna,S. Issam,BEN SASSI Mouna,O. Saidane,S. Bouden,Ben Brahim Takoua,Ben Abdelghani Kawther,L. Metoui,H. Sahli,I. Mahmoud,L. Abdelmoula
出处
期刊:Drug metabolism and personalized therapy [De Gruyter]
卷期号:38 (1): 79-85 被引量:2
标识
DOI:10.1515/dmpt-2021-0236
摘要

Abstract Objectives Leflunomide is a commonly used treatment for rheumatoid arthritis. It acts by inhibiting dihydroorotate dehydrogenase through its active metabolite teriflunomide. The objective of the study was to investigate the relation between plasma-concentration of teriflunomide and disease-activity in rheumatoid arthritis. Methods Data were collected from patients with rheumatoid arthritis on a stable leflunomide dose for at least 2 months. Socio-demographic data, disease characteristics and DAS28 score were recorded. Blood samples were taken for determination of teriflunomide concentration. Results A total of 32 serum concentration-time measurements were collected. The concentration of teriflunomide was positively correlated with disease duration of RA (r 2 =0.2264) and the number of swollen joints (r 2 =0.2413). There was a trend towards a positive correlation between Health Assessment Questionnaire (HAQ) and plasma teriflunomide concentration (r 2 =0.1699). Weight was negatively correlated with the residual plasma concentration of teriflunomide (r 2 =0.2483). However, there was no significant correlation between residual-plasma-concentration of teriflunomide and the following parameters: age, sex, number of tender painful joints, patient-global-assessment, C-reactive protein (CRP) and duration of prescription of leflunomide. We did not find association between disease-activity and residual-plasma-concentration of teriflunomide (r 2 =0.0021) and haven’t been able to define the threshold value of residual-plasma-concentration of leflunomide predictive of a good-response. Conclusions We did not find a concentration-effect-relationship. However, therapeutic drug monitoring of teriflunomide may be useful to ensure adherence and evaluate toxic-levels in case of adverse-events.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
3秒前
liangye2222发布了新的文献求助10
4秒前
4秒前
小毛驴完成签到,获得积分10
4秒前
5秒前
Huang_being发布了新的文献求助10
6秒前
refraincc发布了新的文献求助10
8秒前
song发布了新的文献求助10
10秒前
量子星尘发布了新的文献求助10
11秒前
Orange应助BeBrave1028采纳,获得10
11秒前
Andrew完成签到,获得积分10
11秒前
12秒前
独特元蝶完成签到,获得积分20
12秒前
醉熏的灵发布了新的文献求助30
12秒前
cyyyyyyyyyy完成签到,获得积分10
14秒前
何1发布了新的文献求助10
14秒前
yang完成签到,获得积分10
15秒前
深情安青应助冬瓜熊采纳,获得10
15秒前
17秒前
cindywu发布了新的文献求助10
17秒前
白先生完成签到 ,获得积分10
18秒前
二哥和他的长毛黄完成签到,获得积分10
19秒前
19秒前
19秒前
科研通AI2S应助refraincc采纳,获得10
20秒前
21秒前
官官发布了新的文献求助10
22秒前
555557应助年轻的烨华采纳,获得10
22秒前
25秒前
hjjjjj1发布了新的文献求助10
25秒前
27秒前
冬瓜熊发布了新的文献求助10
27秒前
白桥发布了新的文献求助10
28秒前
29秒前
sjie完成签到 ,获得积分10
30秒前
平淡的凝竹完成签到,获得积分10
31秒前
林正心发布了新的文献求助20
31秒前
hjjjjj1完成签到,获得积分10
32秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988975
求助须知:如何正确求助?哪些是违规求助? 3531316
关于积分的说明 11253424
捐赠科研通 3269917
什么是DOI,文献DOI怎么找? 1804830
邀请新用户注册赠送积分活动 882063
科研通“疑难数据库(出版商)”最低求助积分说明 809068